1. Haider A, Spurling BC, Sánchez-Manso JC. Lewy Body Dementia. In: StatPearls. Treasure Island (FL): StatPearls 2023.
2. Torumkuney D, Aktas Z, Unal S, van Hasselt J, Seyhun Y, Keles N. Country data on AMR in Türkiye in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome. J Antimicrob Chemother. 2022;77(1):i51-i60. doi:10.1093/jac/dkac217.
3. Zhao C, Yang S, Zhang F, et al. Antimicrobial resistance trends of the most common causative pathogens associated with community-acquired respiratory infections in China: 2009-2018. Infect Drug Resist. 2022;15:5069-5083. doi:10.2147/idr.S374805
4. Testing ECoAS. EUCAST-clinical breakpoints and interpretation: EUCAST/ESCMID
5. Gülay Z. Turkish Society of Clinical Microbiology (KLİMUD). Guideline for the Analysis and Presentation of Antimicrobial Susceptibility Data. 2019;1.
6. Zarakolu P, Soyletir G, Gur D, Unal S. Antimicrobial resistance patterns of respiratory pathogens: a local report from Turkey. Clin Microbiol Infect. 2003;9(12):1257-1258. doi:10.1111/j.1469-0691.2003.00780.x
7. Republic of Türkiye Ministry of Health, General Directorate of Public Health. National Antimicrobial Resistance Surveillance Network (UAMDS) Annual Report 2022–2023. Ankara, Türkiye; 2025.
8. Gür D, Ozalp M, Sümerkan B, et al. Prevalence of antimicrobial resistance in Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis and Streptococcus pyogenes: results of a multicentre study in Turkey. Int J Antimicrob Agents. 2002;19(3):207-211. doi:10.1016/s0924-8579(02)00003-1
9. Sener B, Tunçkanat F, Ulusoy S, et al. A survey of antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae in Turkey, 2004 2005. J Antimicrob Chemother. 2007;60(3):587-593. doi:10.1093/jac/dkm232
10. Hascelik G, Sancak B, Kasikci M. A twenty years’ results of the antimicrobial resistance profile and multidrug resistance trend of invasive Streptococcus pneumoniae isolates recovered from adult patients in Turkey: a literature review. Indian J Med Microbiology. 2022; 40(3):342-346. doi:10.1016/j.ijmmb.2022.06.004
11. Gür H, Hazırolan G. Haemophilus influenza suşlarının antibiyotik duyarlılık profillerinin ve Beta-Laktamaz aktivitesinin araştırılması. ANKEM Dergisi. 2020;34(1):18-24. doi:10.5222/ankem.2020.018
12. Yagci A, Ilki A, Akbenlioglu C, et al. Surveillance of Haemophilus influenzae among respiratory tract samples of Turkish children. Int J Antimicrob Agents. 2003;22(5):548-550. doi:10.1016/s0924-8579(03)00242-5
13. Kuvat N, Nazik H, Berkiten R, Öngen B. TEM-1 and ROB-1 presence and antimicrobial resistance in Haemophilus influenzae strains, Istanbul, Turkey. Southeast Asian J Trop Med Public Health. 2015;46(2):254-261.
14. Gonullu N, Catal F, Kucukbasmaci O, Ozdemir S, Torun MM, Berkiten R. Comparison of in vitro activities of tigecycline with other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in two university hospitals in Istanbul, Turkey. Chemotherapy. 2009;55(3):161-167. doi:10.1159/000214144
15. Berkiten R. Türkiye’de Haemophilus influenzae: Beta-laktamaz pozitifliği ve antibiyotiklere direnç (1987–2002). ANKEM Dergisi. 2004; 18(1):53-60.
16. Kılıç H, Akyol S, Parkan ÕM, Dinç G, Sav H, Aydemir G. Molecular characterization and antibiotic susceptibility of Haemophilus influenzae clinical isolates. Infez Med. 2017;25(1):27-32.
17. Uskudar Guclu A, Altay Kocak A, Akcil Ok M, Tutluoglu B, Basustaoglu AC. Antibacterial resistance in lower respiratory tract bacterial pathogens: a multicenter analysis from Turkey. J Infect Dev Ctries. 2021; 15(2):254-262. doi:10.3855/jidc.12599.